In last trading session, NKGen Biotech Inc (NASDAQ:NKGN) saw 0.21 million shares changing hands with its beta currently measuring 0.53. Company’s recent per share price level of $0.57 trading at $0.01 or 2.23% at ring of the bell on the day assigns it a market valuation of $20.33M. That closing price of NKGN’s stock is at a discount of -612.28% from its 52-week high price of $4.06 and is indicating a premium of 64.91% from its 52-week low price of $0.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.51 million shares which gives us an average trading volume of 1.40 million if we extend that period to 3-months.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Upright in the green during last session for gaining 2.23%, in the last five days NKGN remained trading in the red while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $0.57 price level, adding 23.55% to its value on the day. NKGen Biotech Inc’s shares saw a change of -12.62% in year-to-date performance and have moved -12.62% in past 5-day. NKGen Biotech Inc (NASDAQ:NKGN) showed a performance of 30.59% in past 30-days. Number of shares sold short was 0.72 million shares which calculate 0.77 days to cover the short interests.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Insiders are in possession of 41.34% of company’s total shares while institution are holding 12.19 percent of that, with stock having share float percentage of 20.78%. Investors also watch the number of corporate investors in a company very closely, which is 12.19% institutions for NKGen Biotech Inc that are currently holding shares of the company.